Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Institut national de la recherche scientifique

$36,000.00

New strategies for the total synthesis of microbial glycans

FY 2024-25

Summary
The microbial world represents an inexhaustible source of sugar-derived molecules, showing astonishing structural diversity, biological functions, and therapeutic properties. As sugar-derived metabolites are found in the form of complex mixtures, chemical synthesis of microbial glycans stands as a tantalizing opportunity to gain insight into their biological and therapeutic properties. Along these lines, the main objective of our research program is to develop innovative synthetic approaches enabling the preparation of therapeutically relevant microbial glycans. For the next five-year period, we propose to work on four different research themes, which have been designed to make significant progress toward our long-term goal. In a first theme, we propose to synthesize the repeating unit (RU) of cepacian, a polysaccharide (PS) expressed at the surface of Burkholderia cepacia complex, a group of opportunistic pathogens causing severe nosocomial infections. The RU of cepacian is an oligomer composed of seven sugar residues, some of them bearing ester substituents at specific positions. The presence of a highly branched glucuronic acid residue in a specific "alpha" configuration represents an important synthetic challenge, which we will try to solve capitalizing on intramolecular reactions. In a second theme, we will synthesize compounds that can mimic Kdo, an eight-carbon carboxylic acid-containing bacterial sugar, which stands as a crucial building block for the elaboration of membrane-linked PSs produced by pathogenic Gram-negative bacteria. We will replace the intracyclic oxygen atom of Kdo with a nitrogen to generate an unprecedented library of compounds called "Kdo iminosugars". These sugar mimics could be used to inhibit - or probe - the biosynthesis of bacterial PSs. In a third theme, we will investigate the biosurfactant content of Pantoea ananatis, a non-pathogenic bacterium, which produces glucolipid featuring macrocycles that we have called "ananatosides". We will develop expeditious chemo-enzymatic approaches for the synthesis of ananatoside-like biosurfactants and their more water soluble or dimeric derivatives. In a last research theme, we will investigate how rare bacterial sugars called "idopyranosides" can react to form stable and isolable "glycosidic conformers", which are the same compound presenting two different conformations. Thorough mechanistic insights will be gathered from experimental data and calculations. This knowledge will be applied to the synthesis of the RU of a PS produced by Campylobacter jejuni, a bacterium that is the main trigger of the Guillain-Barré auto-immune syndrome. Several aspects of our research program will lead to fundamental advances in synthetic chemistry. Importantly, the sugar-based compounds that will be prepared over the course of this research program could generate benefits for the health of Canadians as novel therapeutics, prophylactics, and biomaterials.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2022-04515
Name nom
Gauthier, Charles
Department département
Centre Armand-Frappier Santé Biotechnologie
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3702
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Carbohydrates
Research subject fr
Glucides
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
New strategies for the total synthesis of microbial glycans
Keywords
carbohydrate chemistry; natural products; microbial glycans; exopolysaccharide; capsular polysaccharide; glycosylation; 3-deoxy-d-manno-oct-2-ulosonic acid; bacterial glycolipids; biosurfactants; idopyranosides
Application summary
The microbial world represents an inexhaustible source of sugar-derived molecules, showing astonishing structural diversity, biological functions, and therapeutic properties. As sugar-derived metabolites are found in the form of complex mixtures, chemical synthesis of microbial glycans stands as a tantalizing opportunity to gain insight into their biological and therapeutic properties. Along these lines, the main objective of our research program is to develop innovative synthetic approaches enabling the preparation of therapeutically relevant microbial glycans. For the next five-year period, we propose to work on four different research themes, which have been designed to make significant progress toward our long-term goal. In a first theme, we propose to synthesize the repeating unit (RU) of cepacian, a polysaccharide (PS) expressed at the surface of Burkholderia cepacia complex, a group of opportunistic pathogens causing severe nosocomial infections. The RU of cepacian is an oligomer composed of seven sugar residues, some of them bearing ester substituents at specific positions. The presence of a highly branched glucuronic acid residue in a specific "alpha" configuration represents an important synthetic challenge, which we will try to solve capitalizing on intramolecular reactions. In a second theme, we will synthesize compounds that can mimic Kdo, an eight-carbon carboxylic acid-containing bacterial sugar, which stands as a crucial building block for the elaboration of membrane-linked PSs produced by pathogenic Gram-negative bacteria. We will replace the intracyclic oxygen atom of Kdo with a nitrogen to generate an unprecedented library of compounds called "Kdo iminosugars". These sugar mimics could be used to inhibit - or probe - the biosynthesis of bacterial PSs. In a third theme, we will investigate the biosurfactant content of Pantoea ananatis, a non-pathogenic bacterium, which produces glucolipid featuring macrocycles that we have called "ananatosides". We will develop expeditious chemo-enzymatic approaches for the synthesis of ananatoside-like biosurfactants and their more water soluble or dimeric derivatives. In a last research theme, we will investigate how rare bacterial sugars called "idopyranosides" can react to form stable and isolable "glycosidic conformers", which are the same compound presenting two different conformations. Thorough mechanistic insights will be gathered from experimental data and calculations. This knowledge will be applied to the synthesis of the RU of a PS produced by Campylobacter jejuni, a bacterium that is the main trigger of the Guillain-Barré auto-immune syndrome. Several aspects of our research program will lead to fundamental advances in synthetic chemistry. Importantly, the sugar-based compounds that will be prepared over the course of this research program could generate benefits for the health of Canadians as novel therapeutics, prophylactics, and biomaterials.